SEC Comment Letter 0000000000-23-001672 to CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
Date: Feb. 17, 2023 · CIK: 0001478069 · Accession: 0000000000-23-001672
AI Filing Summary & Sentiment
File numbers found in text: 333-269673
Letter
United States securities and exchange commission logo February 17, 2023 Natalie Bogdanos General Counsel CONTRAFECT Corp 28 Wells Avenue, Third Floor Yonkers, New York 10701 Re:CONTRAFECT Corp Registration Statement on Form S-3 Filed February 9, 2023 File No. 333-269673 Dear Natalie Bogdanos: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Wesley Holmes
Show Raw Text
United States securities and exchange commission logo
February 17, 2023
Natalie Bogdanos
General Counsel
CONTRAFECT Corp
28 Wells Avenue, Third Floor
Yonkers, New York 10701
Re:CONTRAFECT Corp
Registration Statement on Form S-3
Filed February 9, 2023
File No. 333-269673
Dear Natalie Bogdanos:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Wesley Holmes